Navigation Links
Herbal treatment should be estimated

ine per tablets. The dose was one tablet four times daily.

The participants on antihistamines were given a single 10 mg tablet daily. While the butterbur recipients did not report any adverse symptoms, a small number of people taking antihistamines reported side effects, mostly drowsiness and fatigue.

Dr Schapowal states that the group has no data on whether butterbur works as an ongoing treatment, but treatment for allergy sufferers is often restricted to peak periods. He felt that, butterbur should be considered for treating seasonal allergic rhinitis, particularly in cases where the sedative effects of antihistamine need to be avoided.

'"/>




Page: 1 2

Related medicine news :

1. Herbal Drug In Controversy
2. Herbal treatment not to be sneezed at
3. Herbal extract aids in rheumatoid arthritis
4. Herbal supplement ephedra posing threat to peoples health
5. Herbal Remedy Risky for Cancer Patients
6. Herbal remedies can have harmful interaction when taken with drugs for rheumatic arthritis
7. Herbal Remedies For Insomnia And Anxiety May Be Ineffective
8. Herbal remedies to be tested by Zambia for AIDS treatment
9. High concentration of heavy metals in Herbal medicines
10. Law ensuring safety and quality of Herbal drugs
11. Herbal Medicine May Improve Blood Count In AID Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Herbal treatment should estimated

Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Heart Damage After Vascular Surgery Raises Death Risks 48779 1Heart Damage After Vascular Surgery Raises Death Risks 48779 2Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 1Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 2Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 3WVU Doctor Works to Reduce Cancer Burden in Africa 48775 1WVU Doctor Works to Reduce Cancer Burden in Africa 48775 2